keeogo

Keeogo for Hip Osteoarthritis

Articles - , , , , , -

Hip osteoarthritis is a chronic disease affecting the joint and surrounding musculature resulting in structural and functional failure of the hip joint and causing pain, disability, and reduced quality of life.

Osteoarthritis is a leading cause of musculoskeletal pain and disability. A recent Global Burden of Diseases study, published in The Lancet in 2012, found that, of the musculoskeletal conditions, the burden associated with osteoarthritis is amongst the most rapidly increasing. Hip osteoarthritis is extremely debilitating for affected individuals. Pain is a dominant symptom, becoming persistent and more limiting as disease progresses. Patients with hip osteoarthritis also report difficulty with functional activities such as walking, driving, stair-climbing, gardening, and housekeeping as well as higher levels of anxiety and depression. Work productivity is affected with greater absenteeism, while fatigue and sleep problems are common. Furthermore, people with osteoarthritis typically suffer from a range of co-morbid diseases that further increases their likelihood of poor physical function.

Hip osteoarthritis also imposes a substantial economic burden, with most costs related to a range of conservative and surgical treatments, lost productivity, and substantial loss of quality of life. In particular, rates of costly hip joint replacement surgery for advanced disease are increasing including a shift in the demographic of recipients to younger patients. Clearly hip osteoarthritis is associated with considerable individual and societal burden and, given that there is currently no cure for the disease, treatments that reduce symptoms and slow functional decline are needed.

A recent technological breakthrough has allowed patients with hip osteoarthritis to achieve a remarkable improvement in their lifestyle and improve voluntary coordination of muscle movements. Without the KeegoTM device, patients had a difficult time moving their legs, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. Same patients wearing a KeegoTM device were able to achieve healthy movement patterns during several clinical trials. These same patients were able to walk about quicker, had no trouble walking up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

If you have been affected by Hip Ostearthritis, please see a specialist at the PRI clinic. This multi-disciplinary team is specifically trained to properly introduce your body to the KeegoTM device, which will allow your body to achieve a remarkable improvement in your lifestyle.

 

Keeogo for Multiple Sclerosis

Articles - , , , , -

Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease in the central nervous system. According to date, it affects more than 2 million people worldwide, including over 500,000 in North America. It is punctuated by fully or partially reversible episodes of neurologic disability, typically lasting days or weeks. Typical symptoms at presentation include but are not limited to:

1. Monocular visual loss due to optic neuritis
2. Limb weakness or sensory loss due to transverse myelitis
3. Double vision due to brain-stem dysfunction
4. Lack of voluntary coordination of muscle movements including gait abnormality due to a cerebella lesion.

After typically 10 to 20 years, a progressive clinical course develops in many of the persons affected, eventually leading to impaired mobility and cognition. Approximately 15% of patients have a progressive course from onset.

More than a dozen or so medications are currently made available to reduce the frequency of transient episodes of neurological disability, yet as of today, no medication fully prevents or reverses neurological deterioration in patients.

Although this conditions cannot yet be fully treated, a recent technological breakthrough has allowed patients with MS to achieve a remarkable improvement in their lifestyle and improve voluntary coordination of muscle movements. Without the KeegoTM device, patients had a difficult time moving their legs, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. Same patients wearing a KeegoTM device were able to achieve healthy movement patterns during several clinical trials. These same patients were able to walk about quicker, had no trouble walking up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

If you have been affected by Multiple Sclerosis, please see a specialist at the PRI clinic. This multi-disciplinary team is specifically trained to properly introduce your body to the KeegoTM device, which will allow your body to achieve a remarkable improvement in your lifestyle.

Keeogo for Stroke

Articles - , , , , -

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. “Mini-strokes” or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Symptoms of stroke are

•Sudden numbness or weakness of the face, arm or leg (especially on one side of the body)

•Sudden confusion, trouble speaking or understanding speech

•Sudden trouble seeing in one or both eyes

•Sudden trouble walking, dizziness, loss of balance or coordination

•Sudden severe headache with no known cause

If you have any of these symptoms, you must get to a hospital quickly to begin treatment. Acute stroke therapies try to stop a stroke while it is happening by quickly dissolving the blood clot or by stopping the bleeding. Post-stroke rehabilitation helps individuals overcome disabilities that result from stroke damage.

After stroke, various rehabilitative techniques help people regain function and lifestyle as much as possible. Your MD may offer blood thinners or other pharmaceutical interventions to help decrease the probability of further strokes from happening. Your physical therapist may offer specific rehabilitative exercises to assist you with regaining proper function of your arms and legs.

A recent technological breakthrough offers patients who suffered from stroke vast lifestyle improvements. Without the KeegoTM device, post-stroke patients had a difficult time moving their legs, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. These same patients wearing a KeegoTM device were able to achieve much more fluid movement patterns during several clinical trials. These same patients were able to move quicker from one location to another, were able to promptly walk up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

Keeogo for Spinal Cord Injury

Articles - , , , , -

Spinal cord injury (SCI) is the injury of the spinal cord which can occur anywhere from head to lower back as a result of compulsion, incision or contusion. The most common causes of SCI in the world are traffic accidents, gunshot injuries, knife injuries, falls and sports injuries. There is a strong relationship between functional status and whether the injury is complete or not complete, as well as the level of the injury.

The results of SCI bring not only damage to independence and physical function, but also include many complications from the injury. Neurogenic bladder and bowel, urinary tract infections, pressure ulcers, orthostatic hypotension, fractures, deep vein thrombosis, spasticity, pulmonary and cardiovascular problems, and depressive disorders are frequent complications after SCI.

SCI leads to serious disability in the patient resulting in the loss of work, which brings psychosocial and economic problems. The treatment and rehabilitation period is long, expensive and exhausting in SCI. Whether complete or incomplete, SCI rehabilitation is a long process that requires patience and motivation of the patient and relatives. Early rehabilitation is important to prevent joint contractures and the loss of muscle strength, conservation of bone density, and to ensure normal functioning of the respiratory and digestive system. An interdisciplinary approach is essential in rehabilitation in SCI, as in the other types of rehabilitation. The team is led by a physiatrist and consists of the patients’ family, physiotherapist, occupational therapist, dietician, psychologist, speech therapist, social worker and other consultant specialists is often necessary.

A recent technological breakthrough has allowed patients with SCI to expedite the lifestyle improvement process. Without the KeegoTM device, patients with SCI had a difficult time moving their legs, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. These same patients wearing a KeegoTM device were able to achieve much more fluid movement patterns during several clinical trials. These same patients were able to move quicker from one location to another, were able to promptly walk up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

Keeogo for Knee Hip Osteoarthritis

Articles - , , , , , , -

Osteoarthritis (OA) of the knee and hip is the most common chronic condition affecting patients over the age of 70. It is estimated that in adults over the age of 30, up to 6% of adults are symptomatic of knee arthritis and around 3% are symptomatic of hip arthritis. The prevalence of osteoarthritis increases with age, and with an aging population, the effect of this disease will represent an ever-increasing burden on health care.

Osteoarthritis of the hip and knee is the most common cause of difficulty in walking. It has a huge impact on the economy, with absence from work and early retirement exceeding 2% of the gross domestic product. It is estimated that over 1 million total hip replacements are performed worldwide each year, and in Canada and the United States alone it is predicted that between 1995 and 2020 an additional 19 million people a year will be affected by arthritis.

When the biomechanics of the hip and knee joint are altered or overused, the joint becomes more prone to the changes of osteoarthritis. Anatomical variants in hip morphology in the population have been linked to the development of osteoarthritis.

Obesity, previous knee injury, and sports activity have been shown to be risk factors for the incidence but not disease progression of OA of the knee. In the Western world up to 23.6% of men and 23.8% of women are regarded as obese. Both men and women with a BMI > 28 have been found to be 1.7 times more likely to have hip OA than those with a BMI < 24.5 . Occupational habits are also known to be a risk factor, with the risk of knee OA significantly elevated in those whose job involves more than 30 minutes per day squatting, kneeling, or climbing stairs, with one study finding the prevalence rate of osteoarthritis in female cleaners over six times higher than expected. The impact of sports activity and previous injury has also been shown to be a risk factor for developing OA. In a group of retired England football players, 51% of players who retired through a football related injury were diagnosed with lower-limb OA compared with 25% of players who did not retire through injury. A recent technological breakthrough has allowed patients with hip and knee OA to achieve a remarkable improvement in their lifestyle. Without the KeegoTM device, patients had a difficult time moving their legs, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. Same patients wearing a KeegoTM device were able to achieve healthy movement patterns during several clinical trials. These same patients were able to walk about quicker, had no trouble walking up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

Keeogo for Parkinson’s Disease

Articles - , , , , -

Parkinson’s disease (PD) was first described by Dr. James Parkinson in 1817 as a “shaking palsy.” It is a chronic, progressive neurodegenerative disease characterized by both motor and non-motor features.

The disease has a significant clinical impact on patients, families, and caregivers through its progressive degenerative effects on mobility and muscle control. The motor symptoms of PD are attributed to the loss of striatal dopaminergic neurons, although the presence of non-motor symptoms supports neuronal loss in non-dopaminergic areas as well. The term parkinsonism is a symptom complex used to describe the motor features of PD, which include resting tremor, bradykinesia, and muscular rigidity. PD is the most common cause of parkinsonism, although a number of secondary causes also exist, including diseases that mimic PD and drug-induced causes.

Although it is primarily a disease of the elderly, individuals have developed PD in their 30s and 40s. Gender differences pertaining to the incidence of PD are reflected in a 3:2 ratio of males to females, with a delayed onset in females attributed to the neuroprotective effects of estrogen on the nigrostriatal dopaminergic system.

PD’s variable but pronounced progression has a significant impact on patients, families, and society. Advanced and end-stage disease may lead to serious complications, including pneumonia, which are often associated with death. Current treatment is focused on symptomatic management. Evidence suggests that PD patients may also benefit from a multidisciplinary approach to care that includes movement specialists, social workers, pharmacists, and other health care practitioners.

A recent technological breakthrough has allowed patients with PD to achieve a remarkable improvement in their lifestyle. Without the KeegoTM device, patients walked slowly, had to stop when taking stairs from exhaustion, had a difficult time picking up objects from the floor, exerted strenuous effort, when getting up from a chair to walk down the hall. Patients with PD wearing a KeegoTM device were able to achieve healthy movement patterns during several clinical trials. The same patients were able to walk about quickly, had no trouble walking up or down the stairs, picked up objects from the floor with little effort, and were able to easily sit down, and get up from the seat without propping themselves up with their hands.

Opening Hours


Days Hours
Monday - Friday 8.00 - 17.00
Saturday 9.30 - 17.30
Sunday 9.30 - 15.00

Search Form

Categories

Recent Posts

Recent Comments